Conversations and healthy debate about issues facing our industry and the health care system are critical to addressing some of today’s challenges and opportunities. The Catalyst welcomes guest contributors, including patients, stakeholders, innovators and others, to share their perspectives and point of view. Today, we are pleased to welcome a guest post from Eduardo Cetlin, President, Amgen Foundation on the work to bring more STEM opportunities to young people as well as advancing racial equity in STEM education.
Now more than ever, there is a global need to prepare the next generation to tackle tomorrow’s challenges. To get there, we need to create effective opportunities for students to explore the scientific process and make new discoveries. Unfortunately, too many young people still lack opportunities to engage meaningfully in this process, which has led to clear and significant gaps in diversity across scientific fields and in scientific literacy overall.
For nearly 30 years, the Amgen Foundation has sought to advance excellence in science education. As students are kept out of classrooms due to the COVID-19 pandemic, we’re seeing the need for quality remote learning rise as a global priority. It has become increasingly important that teachers and students have the resources they need, which is why the Amgen Foundation is committed to creating opportunities so students and educators can continue, and thrive in, science learning even during “COVID times.”
Our north star is to level the playing field so that all learners have access to high-quality science education. That’s why we support free virtual learning platforms, such as Khan Academy and LabXchange, so students everywhere can experience the trial and error that comes with science learning.
With the Amgen Foundation’s support since 2015, Khan Academy has grown its online biology offering to more than 300 videos, 80 exercise sets and 195 articles. The Amgen Foundation recently awarded Khan Academy an additional $3 million to support the platform’s biology content and deepen its partnership with LabXchange.
Made possible by the Amgen Foundation and Harvard University, LabXchange launched in January on the UN International Day of Education with the goal of providing users with access to personalized instruction, virtual lab experiences, and networking opportunities across the global scientific community.
Our goal is that platforms like Khan Academy and LabXchange will help students find courses and aspects of science that excite them outside of the hands-on environment a classroom provides. LabXchange in particular is a space where people can come together to collaborate and think about ways to address the challenges we face, whether it’s a global pandemic or finding a cure for cancer.
These unprecedented times have also put a spotlight on the issues surrounding racial inequity. These issues affect every aspect of American society, and in response to the recent national and international movement, the Amgen Foundation committed $7.5 million to help advance racial justice – with $2.5 million immediately distributed to national organizations such as the Equal Justice Initiative and Echoing Green, while other funds will be dedicated to local efforts in Amgen communities as well as advancing racial equity in STEM education. As part of the renewed grant to Khan Academy, the Amgen Foundation will also support three underserved school districts that are now facing budget cuts due to COVID-19. This will enable these districts to receive the training, support, and analytics necessary to bring Khan Academy to every classroom in their district. Unfortunately, for many children in the U.S., a zip code often drives educational outcomes.
With all the pressures our communities are facing, including the ambiguity about what the future of in-person learning will look like, it’s still important to keep students on track for success. If there ever was a time for us to work together for progress, to ensure equity and access to science literacy, it’s now.
Guest Contributor
The PhRMA blog welcomes guest contributors, including patients, stakeholders, innovators and others, to share their perspectives and point of view on issues facing our industry and the health care system.
Guest Contributor
Celebrating STEM Day: Investing in America’s innovators
Recent events highlight progress on health equity
ICYMI: PhRMA’s 4th Annual Pathways to Success: Virtual STEM Career Expo
Hispanic Heritage Month: Fighting for Hispanic patients
PhRMA awards grants to 2024 Annual Pathways to Success: Virtual STEM Career Expo Partners
Industry-backed STEM programs have supported 111 million students and nearly 183,000 teachers
How government price setting fails to address systemic health care inequities
Women’s Health Month: A conversation with Sage
Championing cancer equity: Our drive for healthier AANHPI communities
New analysis: Accelerated approval pathway is changing lives in underserved communities
PhRMA provides grant funding to support the Morehouse School of Medicine Satcher Health Leadership Institute’s Health Equity Tra
New social determinants of health simulation explores structural barriers patients face accessing and affording medicines
PhRMA awards grants to 2023 Annual Pathways to Success Graduate Summit Partners
Between hope and despair: Improving cancer outcomes
PhRMA awards grant to Emerson Diversity Health Foundation
PhRMA Otorga Beca a la “Emerson Diversity Health Foundation”
Using traditional HTAs to determine coverage threatens patient access to medicine
Traditional HTAs keep diverse patients out of the conversation
Traditional HTA methods treat everyone like the “average” patient
You won’t fix what you don’t value: Two reasons why traditional cost-effective analyses can perpetuate health inequities
Potential gene therapies bring hope to patients with sickle cell disease
Stephanie Dyson of BMS on reducing health disparities
Sharing rebates can save Americans with diabetes 500 each year and improve adherence
Announcing CAREs Grant Round 4
Announcing CAREs Grant Round 4
Guest Series: PhRMA talks racial and health equity with Lauren Powell, VP US Health Equity and Community Wellness, Takeda
PhRMA awards $75,000 to fund initiatives to reduce health inequities
Watch: Building trust and enhancing clinical trial diversity
More than 800 medicines are in development for diseases that disproportionately affect racial and ethnic communities
PhRMA hosts first stakeholder workshop on clinical trial diversity
PhRMA CAREs Grant request for proposals: Addressing inequities in access to COVID-19 testing, therapeutics and vaccines
PhRMA member companies share how they are improving clinical trial diversity
Guest post: PhRMA talks racial and health equity with Stephanie Dyson, Head of Office at Biogen
Paper finds gaps in health data are a barrier to health equity
New research shows hotspots of inequity relate to increased COVID-19 hospitalizations
American biopharmaceutical manufacturing: Fueling economic growth now and for years to come
Increasing diversity at investigator sites could increase minority participation in clinical trials
Report highlights biopharmaceutical industry’s commitment to D&I
Strengthening a culture dedicated to patients and equity: A conversation with Percival Barretto-Ko, President of Astellas US
PhRMA CAREs Grant request for proposals: Addressing racial disparities in medication utilization and adherence
Committing to diversity, equity and inclusion: A call to action for clinical trials
Just released: PhRMA members’ new clinical trial diversity principles
ICYMI: Addressing health inequities: Biopharmaceutical companies are rising to the occasion
Guest Post: Honoring Hispanic Heritage Month by taking action on health equity
New Report: The biopharmaceutical industry’s sustained commitment to inspiring and advancing tomorrow’s STEM workforce
Manufacturing Day 2020: A closer look at the biopharmaceutical industry’s contributions
Sharing rebates can improve access to medicines and increase health equity
PhRMA will continue to advocate for equity within our industry
Three ways the pharmaceutical industry can positively impact health equity
Systemic racism is as real as any disease, and our industry is not immune
Guest Post: Pride started with protest: Combatting the dual pandemics of COVID-19 and racism this Pride Month
PhRMA awards $100,000 to fund projects that address health inequalities
Observing National Minority Health Month in the age of COVID-19
New report: Biopharmaceutical industry supports over 4 million jobs and $1.1 trillion in U.S. economic output
New Report: Advanced manufacturing powering innovative biopharmaceuticals
Guest Post: The importance of women, diversity and inclusion in STEM
Event: New era of medicine comes to Capitol Hill
Guest Post: Amgen Foundation stands for equal opportunities in STEM learning
STEM
Health Equity
Guest Post: Amgen Foundation stands for equal opportunities in STEM learning
Guest Post: Amgen Foundation stands for equal opportunities in STEM learning